330 related articles for article (PubMed ID: 29916193)
1. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
[TBL] [Abstract][Full Text] [Related]
2. Co-Processed Excipients for Dispersible Tablets-Part 2: Patient Acceptability.
Dziemidowicz K; Lopez FL; Bowles BJ; Edwards AJ; Ernest TB; Orlu M; Tuleu C
AAPS PharmSciTech; 2018 Aug; 19(6):2646-2657. PubMed ID: 29943280
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).
Woyna-Orlewicz K; Brniak W; Tatara W; Strzebońska M; Haznar-Garbacz D; Szafraniec-Szczęsny J; Antosik-Rogóż A; Wojteczko K; Strózik M; Kurek M; Jachowicz R; Mendyk A
Pharm Res; 2023 Dec; 40(12):2947-2962. PubMed ID: 37726407
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
Kokott M; Lura A; Breitkreutz J; Wiedey R
Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
[TBL] [Abstract][Full Text] [Related]
6. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
Solanki NG; Kathawala M; Serajuddin ATM
J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Flow and Compression Properties of Four Lactose-Based Co-Processed Excipients: Cellactose
Dominik M; Vraníková B; Svačinová P; Elbl J; Pavloková S; Prudilová BB; Šklubalová Z; Franc A
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575562
[TBL] [Abstract][Full Text] [Related]
8. Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics.
Suárez-González J; Santoveña-Estévez A; Soriano M; Fariña JB
Drug Dev Ind Pharm; 2020 Feb; 46(2):309-317. PubMed ID: 31944867
[No Abstract] [Full Text] [Related]
9. Development and Optimization of a Starch-Based Co-processed Excipient for Direct Compression Using Mixture Design.
Apeji YE; Oyi AR; Isah AB; Allagh TS; Modi SR; Bansal AK
AAPS PharmSciTech; 2018 Feb; 19(2):866-880. PubMed ID: 29038987
[TBL] [Abstract][Full Text] [Related]
10. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
[TBL] [Abstract][Full Text] [Related]
11. Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics.
Yasmin R; Shoaib MH; Ahmed FR; Qazi F; Ali H; Zafar F
PLoS One; 2020; 15(2):e0223201. PubMed ID: 32050259
[TBL] [Abstract][Full Text] [Related]
12. The Influence of the Polymer Type on the Quality of Newly Developed Oral Immediate-Release Tablets Containing Amiodarone Solid Dispersions Obtained by Hot-Melt Extrusion.
Fița AC; Secăreanu AA; Musuc AM; Ozon EA; Sarbu I; Atkinson I; Rusu A; Mati E; Anuta V; Pop AL
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235137
[TBL] [Abstract][Full Text] [Related]
13. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
14. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
[TBL] [Abstract][Full Text] [Related]
15. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
16. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
Bejugam NK; Mutyam SK; Shankar GN
Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
[TBL] [Abstract][Full Text] [Related]
17. Co-processed excipients for direct compression of tablets.
Franc A; Vetchý D; Vodáčková P; Kubaľák R; Jendryková L; Goněc R
Ceska Slov Farm; 2018 Dec; 67(5-6):175-181. PubMed ID: 30871322
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
[TBL] [Abstract][Full Text] [Related]
19. Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press.
Lura A; Elezaj V; Kokott M; Fischer B; Breitkreutz J
Int J Pharm; 2021 Jun; 602():120636. PubMed ID: 33895296
[TBL] [Abstract][Full Text] [Related]
20. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K
Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
